CopiktraActive Ingredient(s): Duvelisib
FDA Approved: * September 24, 2018
Pharm Company: * VERASTEM INC
Duvelisib, sold under the brand name Copiktra, is a medication used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma after other treatments have failed. It is taken by mouth. Common side effects include diarrhea, low white blood cells, rash, feeling tired, fever, and muscle pains. Other serious side effects include inflammation of the lungs and infections. It is a ... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.